Ablation after ICD implantation - Bridging the gap between promise and practice

New England Journal of Medicine

Volumn 357, Issue 26, 2007, Pages 2717-2719

  Estes III, N A Mark ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ARRHYTHMOGENESIS; CATHETER ABLATION; CORONARY ARTERY DISEASE; DEATH; DEFIBRILLATOR; EDITORIAL; HEART ARREST; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RADIOFREQUENCY ABLATION; SURVIVAL;

EID: 37549042448     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0706860     Document Type: Editorial

References (15)

1. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114(10):e385-e484.
2. Huikuri HV, Castellanos A, Myerburg RJ. Sudden death due to cardiac arrhythmias. N Engl J Med 2001;345:1473-82.
3. DiMarco JP. Implantable cardioverter-defibrillators. N Engl J Med 2003;349:1836-47.
4. Goldberger Z, Lampert R. Implantable cardioverter-defibrillators: expanding indications and technologies. JAMA 2006;295:809-18.
5. Hlatky MA. Evidence-based use of cardiac procedures and devices. N Engl J Med 2004;350:2126-8.
6. Morady F. Radiofrequency ablation as treatment for cardiac arrhythmias. N Engl J Med 1999;340:534-44.
7. Marchlinski FE, Callans DJ, Gottlieb CD, Zado E. Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy. Circulation 2000;101:1288-96.
8. Reddy VY, Neuzil P, Taborsky M, Ruskin JN. Short-term results of substrate mapping and radiofrequency ablation of ischemic ventricular tachycardia using a saline-irrigated catheter. J Am Coll Cardiol 2003;41:2228-36.
9. Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med 2007;357:2657-65.
10. Connolly SJ, Dorian P, Roberts RS, et al. Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial. JAMA 2006;295:165-71.
11. Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. N Engl J Med 1999;340:1855-62.
12. Epstein AJ, Wilber DJ, Calkins H, et al. Randomized controlled trial of ventricular tachycardia treatment by cooled tip catheter ablation vs drug therapy. J Am Coll Cardiol 1998;31: Suppl 1:118. abstract.
13. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM. A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006;48:330-9.
14. Dorian P, Philippon F, Thibault B, et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual-chamber implantable cardioverter-defibrillator. Heart Rhythm 2004;1:540-7.
15. Wood MA, Ellenbogen KA. Catheter ablation of chronic atrial fibrillation - the gap between promise and practice. N Engl J Med 2006;354:967-9.